2) Results will differ per disease, depending on the various factors: - Chronic vs acute - Extend of complement activation - The complement protein measured - Kinetics of the activation fragment In these paper ratio's mattered: - https://t.co/OuNnNUIe9j -
@luyimin2009 @KIReports 3.) https://t.co/88lMcpdT7w Here they looked at markers that could disciminate between infection-induced HUS and aHUS. In Figure 4, you can see that only the C3d/C3-ratio was able to discriminate between active disease and remission
Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome. https://t.co/WBLwZlYFoI //www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--production.springer.de-OnlineResources-Logos-springerlink.gif?